Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
8,476,761
-
Share change
-
+8,476,761
-
Total reported value
-
$285,550,000
-
Price per share
-
$33.88
-
Number of holders
-
19
-
Value change
-
+$285,549,980
-
Number of buys
-
19
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q4 2019
As of 31 Dec 2019,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,476,761 shares.
The largest 10 holders included
Artal Group S.A., FMR LLC, PRIMECAP MANAGEMENT CO/CA/, PLATINUM INVESTMENT MANAGEMENT LTD, DekaBank Deutsche Girozentrale, Redmile Group, LLC, MILLENNIUM MANAGEMENT LLC, Laurion Capital Management LP, SCHRODER INVESTMENT MANAGEMENT GROUP, and Vident Investment Advisory, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.